Economic appraisal of antidepressant pha
β
David A. Sclar; Tracy L. Skaer; Linda M. Robison; Julie K. Stowers
π
Article
π
1998
π
John Wiley and Sons
π
English
β 57 KB
π 1 views
In the United States, an estimated $44 billion is expended annually for the treatment, morbidity, and mortality associated with depression. Domestic and international cost-containment initiatives are mandating a demonstration of value for money defined in terms of a measurable health and/or financia